News
I have covered embryonic stem cells since the beginning— even a little bit before the beginning. Here at MIT Technology Review, we broke the story of the quest to isolate these cells ...
Human blastoids can’t develop into people. Yet. As the technology advances, it is looking increasingly likely that one day, stem-cell-derived embryos will be able to develop into living animals.
New Technology Tests Maturity Of Stem Cells Date: May 8, 2008 Source: Fraunhofer-Gesellschaft Summary: Stem cells can differentiate into 220 different types of body cell. The development of these ...
Messenger RNA can travel between different types of stem cells through tunnel-like structures ... called “tunneling nanotubes,” formed between mouse and human cells. Subscribe to Technology Networks’ ...
An innovative fertility technology using stem cells to help an embryo mature outside the body has resulted in the world’s first live human birth. Gameto, the company that developed the approach ...
This finding is particularly relevant for stem cell transplants, applied for the treatment of eg leukemia. Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight ...
This hybrid technology has the potential to transform treatments for neurodegenerative diseases by enhancing the precision and efficacy of stem cell-based therapies. The study's core innovation ...
That results in a relatively small number of stem cells. For that reason, Hsu will likely still need assistive reproductive technology if he wants to start a family. He’s not at that point yet ...
It will take time for either technology to arrive in the clinic. One question is just how durable the enamel made by stem-cell-derived ameloblasts proves to be. Another is how best to deliver the ...
This hybrid technology has the potential to transform treatments for neurodegenerative diseases by enhancing the precision and efficacy of stem cell-based therapies. The study's core innovation ...
Stem cell therapy to treat such ... “We think this will improve the outcome of cell therapy over the vanilla approach using cells in a saline solution.” The two researchers began exploring STH ...
Using DLD microfluidic technology, a label-free cell sorting method which distinguishes between stem cells and blood cells, the platform processed small bone marrow samples (2.5 mL) in just 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results